SPL
0.215
65.4%
PAB
0.001
-50%
YRL
0.26
62.5%
PIL
0.002
-33.3%
ALM
0.006
50%
PRX
0.002
-33.3%
BLZ
0.003
50%
REG
6.76
-26.7%
CNJ
0.006
50%
14D
0.063
-23.2%
M2R
0.003
50%
AN1
0.004
-20%
RLG
0.007
40%
ROG
0.004
-20%
CZN
0.004
33.3%
XGL
0.02
-20%
IXC
0.14
33.3%
SP3
0.026
-16.1%
IXRR
0.004
33.3%
C29
0.023
-14.8%
POD
0.056
33.3%
AZL
0.006
-14.3%
VR1
0.071
31.5%
SHE
0.006
-14.3%
THB
0.019
26.7%
TRI
0.012
-14.3%
HAL
0.029
26.1%
NFM
0.013
-13.3%
DAL
0.059
25.5%
RIM
0.013
-13.3%
ADX
0.035
25%
SNS
0.069
-12.7%
FGH
0.02
25%
ARV
0.007
-12.5%
MGU
0.01
25%
MEG
0.021
-12.5%
RKB
0.005
25%
RPG
0.097
-11.8%
CXU
0.016
23.1%
GLH
0.115
-11.5%
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Lithium Australia (ASX:LIT) lands battery recycling deal

Lithium Australia (ASX:LIT) has announced that its wholly owned subsidiary, Envirostream Australia, has signed an exclusive 3-year recycling agreement with BYD Auto Industry Company. Lithium Australia has signed a new exclusive agreement with BYD Auto Industry Company Limited (BYD Auto) to provide battery recycling services for all New Energy vehicles end-of life batteries in Australia […]

EZZ Life Science Holdings (ASX:EZZ) Creating health supplements that meet identified consumer demand

Ahead of appearing at the Spark+ Australian Equities Day in Singapore, EZZ Life Science Holdings (ASX:EZZ) Chairman, Glenn Cross speaks with The Stock Network’s Lel Smits about: 🧬 Health supplements product range 🧬 Identifying and creating new product opportunities 🧬 Direct-to-consumer and e-commerce market place distribution strategies Watch the full interview ⚡ ️https://youtu.be/gnDoA8DpN6A Register to […]

EZZ Life Science Holdings (ASX:EZZ) Creating health supplements that meet identified consumer demand

EZZ Life Science Holdings (ASX:EZZ) is a life science company focussed on genomic research and development, addressing four key human health challenges: genetic longevity, human papillomavirus (HPV), children’s care, and weight management. The Company formulates, produces and distributes health supplements under the brand of EZZ, and is also an exclusive distributor of skin care products. […]

What’s Hot – GED, MRR, BIO, M2R, LIN, CTT & WTM

What’s Hot, Not & Doing Brought to you by TSN Contributor & Wealth Advisor Nick Kelso What’s Hot – GED, MRR, BIO, M2R, LIN, CTT & WTM What’s Not – MCM What’s Hot GED – Golden Deeps Limited today closed up 164% to finish at 7.4c on $10m stock traded. The reason they were up […]

What’s Hot – MTC, CTT, MQR, KLI, CRD, NIM, HYT, RKT & IMU

What’s Hot, Not & Doing Brought to you by TSN Contributor & Wealth Advisor Nick Kelso What’s Hot – MTC, CTT, MQR, KLI, CRD, NIM, HYT, RKT & IMU What’s Not – MDR What’s Hot MTC – MetalsTech Limited today closed up 44% to finish at 26c on $1m stock traded. The reason they were […]

FBR Limited (ASX:FBR): Brick laying robot systems developer revolutionising building construction

Ahead of appearing at the Spark+ Australian Equities Day in Singapore, FBR’s (ASX:FBR) Mike Pivac speaks with The Stock Network’s Lel Smits about: 🧱 FBR’s robotic brick-laying construction technology 🧱 Highlights from Hadrian X’s structural wall bricklaying robot 🧱 Potential deliverables from US demonstration and revenue outlook Watch the full interview ️ https://youtu.be/vJRwkgBPyHY Register to […]

FBR Limited (ASX:FBR): Brick laying robot systems developer revolutionising building construction

FBR Limited (ASX:FBR) designs, develops and builds dynamically stabilised robots. These robots are designed to work outdoors and use the Company’s proprietary core Dynamic Stabilisation Technology® platform, or DST® for short. The first application of DST® is Hadrian X®, a bricklaying robot that builds structural walls faster, safer, more accurately and with less wastage than […]

Emyria (ASX:EMD) announces ‘promising’ interim clinical results for PTSD Program

Emyria (ASX:EMD) announces ‘promising’ interim clinical results from analysis of its MDMA-assisted therapy for Post-Traumatic Stress Disorder (PTSD) program, which commenced in October 2023. Interim analysis of the first eight patients completing Emyria’s MDMA-assisted therapy (MDMA-AT) program for Post-Traumatic Stress Disorder (PTSD) has demonstrated all patients achieved substantial improvement in PTSD symptoms, with a clinically […]